Gregory Russotti

Direttore Tecnico/Scientifico/R&S presso CENTURY THERAPEUTICS, INC.

Patrimonio netto: 1 M $ in data 30/04/2024

57 anni

Health Technology

Consumer Services

Finance

Posizioni attive di Gregory Russotti

Società	Posizione	Inizio	Fine
CENTURY THERAPEUTICS, INC.	Direttore Tecnico/Scientifico/R&S	01/01/2020	-
	Amministratore Delegato	11/04/2023	04/12/2023
	Presidente	11/04/2023	04/12/2023
Dynamk Capital LLC Dynamk Capital LLC Investment ManagersFinance Dynamk Capital LLC (Dynamk Capital) is a venture capital firm founded in 2017 by Daniella Kranjac and Mario Kranjac. The firm is headquartered in New York, New York.	Consulente / Consigliere	-	-

Società	Posizione	Inizio	Fine
CELGENE	Corporate Officer/Principal	01/10/2017	31/12/2019

Rensselaer Polytechnic Institute	Graduate Degree
Rutgers State University of New Jersey	Doctorate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
CENTURY THERAPEUTICS, INC.	Health Technology

Aziende private	2
Celgene Corp. Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.	Health Technology
Dynamk Capital LLC Dynamk Capital LLC Investment ManagersFinance Dynamk Capital LLC (Dynamk Capital) is a venture capital firm founded in 2017 by Daniella Kranjac and Mario Kranjac. The firm is headquartered in New York, New York.	Finance

Aziende private

Health Technology

Finance